eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
"if the battery in a mechanical mod over-discharges and the device doesn't contain enough air holes to allow the battery to vent, there is a risk of explosion.".